Argatroban (Hospira, Inc.)
Welcome to the PulseAid listing for the Argatroban drug offered from Hospira, Inc.. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | Argatroban |
SUBSTANCE NAME: | ARGATROBAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-01-16 |
END MARKETING DATE: | 0000-00-00 |
Argatroban HUMAN PRESCRIPTION DRUG Details:
Item Description | Argatroban from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 2017-01-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-1140_5e4d31b2-2e02-4703-9f76-d889ee3e8930 |
PRODUCT NDC: | 0409-1140 |
APPLICATION NUMBER: | ANDA204120 |
Other ARGATROBAN Pharmaceutical Manufacturers / Labelers: